Brisbane company trials new drug on US COVID-19 patients in bid to curb severe reactions
A Brisbane biotech company creates an anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States in a bid to prevent people dying from the virus.
0 Response to "Brisbane company trials new drug on US COVID-19 patients in bid to curb severe reactions"
Post a Comment